Work

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA

Year: 2017

Type: article

Abstract: Virtually all lymphoplasmacytic malignancies (LPM) defined by the presence of a monoclonal protein are preceded by monoclonal gammopathy of undetermined significance (MGUS).[1][1] Two large population-based landmark studies have determined the progression rates of the two types of MGUS, those with

Source: Haematologica

DOI: 10.3324/haematol.2017.179978

Authors: Ronald S. Go, Herbert C. Heien, Lindsey R. Sangaralingham, Elizabeth B. Habermann, Nilay D. Shah

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157